Abstract 5132: Discovery and preclinical evaluation of a potent, orally bioavailable, highly selective, small molecule non-covalent KRAS[G12D] inhibitor
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: ChemDiv (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148644390
Cites:
Cited by:
Related to:
